The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-Silico Drug Discovery Market Research Report 2024
Synopsis
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The global In-Silico Drug Discovery market was valued at US$ 1991 million in 2023 and is anticipated to reach US$ 4413.6 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
Report Scope
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Silico Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The global In-Silico Drug Discovery market was valued at US$ 1991 million in 2023 and is anticipated to reach US$ 4413.6 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
Report Scope
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Silico Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Silico Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software as a Service (Cloud)
1.2.3 Consultancy as a Service
1.2.4 Software
1.3 Market by Application
1.3.1 Global In-Silico Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Industry
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Silico Drug Discovery Market Perspective (2019-2030)
2.2 In-Silico Drug Discovery Growth Trends by Region
2.2.1 Global In-Silico Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Silico Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 In-Silico Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 In-Silico Drug Discovery Market Dynamics
2.3.1 In-Silico Drug Discovery Industry Trends
2.3.2 In-Silico Drug Discovery Market Drivers
2.3.3 In-Silico Drug Discovery Market Challenges
2.3.4 In-Silico Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Silico Drug Discovery Players by Revenue
3.1.1 Global Top In-Silico Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global In-Silico Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global In-Silico Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Silico Drug Discovery Revenue
3.4 Global In-Silico Drug Discovery Market Concentration Ratio
3.4.1 Global In-Silico Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Silico Drug Discovery Revenue in 2023
3.5 In-Silico Drug Discovery Key Players Head office and Area Served
3.6 Key Players In-Silico Drug Discovery Product Solution and Service
3.7 Date of Enter into In-Silico Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Silico Drug Discovery Breakdown Data by Type
4.1 Global In-Silico Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global In-Silico Drug Discovery Forecasted Market Size by Type (2025-2030)
5 In-Silico Drug Discovery Breakdown Data by Application
5.1 Global In-Silico Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global In-Silico Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Silico Drug Discovery Market Size (2019-2030)
6.2 North America In-Silico Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Silico Drug Discovery Market Size by Country (2019-2024)
6.4 North America In-Silico Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Silico Drug Discovery Market Size (2019-2030)
7.2 Europe In-Silico Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Silico Drug Discovery Market Size by Country (2019-2024)
7.4 Europe In-Silico Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Silico Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific In-Silico Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Silico Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Silico Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Silico Drug Discovery Market Size (2019-2030)
9.2 Latin America In-Silico Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Silico Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America In-Silico Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Silico Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa In-Silico Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Silico Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Silico Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In-Silico Drug Discovery Introduction
11.1.4 Charles River Revenue in In-Silico Drug Discovery Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Certara USA, Inc.
11.2.1 Certara USA, Inc. Company Detail
11.2.2 Certara USA, Inc. Business Overview
11.2.3 Certara USA, Inc. In-Silico Drug Discovery Introduction
11.2.4 Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2019-2024)
11.2.5 Certara USA, Inc. Recent Development
11.3 Evotec
11.3.1 Evotec Company Detail
11.3.2 Evotec Business Overview
11.3.3 Evotec In-Silico Drug Discovery Introduction
11.3.4 Evotec Revenue in In-Silico Drug Discovery Business (2019-2024)
11.3.5 Evotec Recent Development
11.4 Dassault System (Biovia)
11.4.1 Dassault System (Biovia) Company Detail
11.4.2 Dassault System (Biovia) Business Overview
11.4.3 Dassault System (Biovia) In-Silico Drug Discovery Introduction
11.4.4 Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2019-2024)
11.4.5 Dassault System (Biovia) Recent Development
11.5 Albany Molecular Research Inc. (AMRI)
11.5.1 Albany Molecular Research Inc. (AMRI) Company Detail
11.5.2 Albany Molecular Research Inc. (AMRI) Business Overview
11.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Introduction
11.5.4 Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2019-2024)
11.5.5 Albany Molecular Research Inc. (AMRI) Recent Development
11.6 Selvita
11.6.1 Selvita Company Detail
11.6.2 Selvita Business Overview
11.6.3 Selvita In-Silico Drug Discovery Introduction
11.6.4 Selvita Revenue in In-Silico Drug Discovery Business (2019-2024)
11.6.5 Selvita Recent Development
11.7 Schrödinger, Inc.
11.7.1 Schrödinger, Inc. Company Detail
11.7.2 Schrödinger, Inc. Business Overview
11.7.3 Schrödinger, Inc. In-Silico Drug Discovery Introduction
11.7.4 Schrödinger, Inc. Revenue in In-Silico Drug Discovery Business (2019-2024)
11.7.5 Schrödinger, Inc. Recent Development
11.8 GVK BIO
11.8.1 GVK BIO Company Detail
11.8.2 GVK BIO Business Overview
11.8.3 GVK BIO In-Silico Drug Discovery Introduction
11.8.4 GVK BIO Revenue in In-Silico Drug Discovery Business (2019-2024)
11.8.5 GVK BIO Recent Development
11.9 OpenEye Scientific Software
11.9.1 OpenEye Scientific Software Company Detail
11.9.2 OpenEye Scientific Software Business Overview
11.9.3 OpenEye Scientific Software In-Silico Drug Discovery Introduction
11.9.4 OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2019-2024)
11.9.5 OpenEye Scientific Software Recent Development
11.10 Chemical Computing Group (CCG)
11.10.1 Chemical Computing Group (CCG) Company Detail
11.10.2 Chemical Computing Group (CCG) Business Overview
11.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Introduction
11.10.4 Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2019-2024)
11.10.5 Chemical Computing Group (CCG) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
